Cagrilintide

Clinical Trials

Cagrilintide

Aliases
CagriSema (combo with semaglutide)
Administration
Subcutaneous injection (once weekly)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

Nausea

A common digestive side effect, often most noticeable when starting or increasing the dose.

Constipation

A common digestive side effect linked to slowed gastric emptying.

Injection site reactions

Mild redness, swelling, or discomfort at the site of injection.